Veterinary Medicines

LIBEO 40 MG CHEWABLE TABLETS FOR DOGS

Authorised
  • Furosemide
Download as PDF

Product identification

Medicine name:
LIBEO 40 MG CHEWABLE TABLETS FOR DOGS
Libeo 40 mg tyggetabletter
Active substance:
  • Furosemide
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Furosemide
    40.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC03CA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:
  • Cardboard box containing 1 blister of 8 tablets
  • Cardboard box containing 25 blisters of 8 tablets
  • Cardboard box containing 15 blisters of 8 tablets
  • Cardboard box containing 12 blisters of 8 tablets
  • Cardboard box containing 2 blisters of 8 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • CEVA Santé Animale
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 51800
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0252/002
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."